Dian Diagnostics Group Co Ltd is committed to upholding strong values and a robust corporate philosophy. The company embodies a customer-centric approach, prioritizing excellence and innovation in providing diagnostic solutions and medical services. Dian Diagnostics Group Co Ltd places great importance on quality, accuracy, and efficiency, ensuring customers receive reliable diagnostic results. With a focus on continuous improvement, the company utilizes cutting-edge technology and a dedicated team of professionals to deliver superior healthcare solutions. Dian Diagnostics Group Co Ltd strives for integrity, transparency, and trustworthiness in all aspects of its operations, establishing itself as a trusted leader in the diagnostic industry.

Dian Diagnostics Group Co Ltd is primarily present in China.

Dian Diagnostics Group Co Ltd has achieved several significant milestones in its history. The company has successfully established itself as a leading player in the diagnostics industry. One of the notable achievements includes its rapid expansion in the Chinese market, leading to a strong presence across the country. Dian Diagnostics Group Co Ltd has also made significant advancements in research and development, resulting in the launch of innovative diagnostic products and solutions. Additionally, the company has formed strategic partnerships with renowned medical institutions, facilitating collaborative efforts in research and improving healthcare outcomes. These milestones demonstrate Dian Diagnostics Group Co Ltd's commitment to growth, innovation, and delivering high-quality diagnostic services.

Dian Diagnostics Group Co Ltd is a renowned company in the healthcare sector. It was founded in 1992 in China and has since become a leading provider of medical diagnostic products and services. The company focuses on offering clinical testing and diagnostic solutions that aid in disease detection and treatment. With years of experience and expertise, Dian Diagnostics Group Co Ltd has developed a strong presence both domestically and internationally. They continue to innovate and expand their product portfolio to meet the evolving needs of the medical industry. Dian Diagnostics Group Co Ltd is committed to improving healthcare outcomes by delivering reliable and efficient diagnostic solutions.

The main competitors of Dian Diagnostics Group Co Ltd in the market are Company A, Company B, and Company C. These companies are also engaged in the diagnostics industry and offer similar products and services. Despite facing competition, Dian Diagnostics Group Co Ltd has established itself as a leading player in the market with its innovative solutions and strong customer relationships. With its commitment to quality and continuous improvement, the company has been able to stay ahead of its competitors and maintain a competitive edge in the industry.

Dian Diagnostics Group Co Ltd is primarily active in the healthcare industry.

Dian Diagnostics Group Co Ltd is a leading company in the healthcare industry. Its business model focuses on providing comprehensive diagnostic services to patients. The company operates a network of diagnostic centers and laboratories, offering a wide range of medical tests and examinations. Dian Diagnostics Group Co Ltd is committed to delivering accurate and timely results, enabling healthcare professionals to make informed decisions for their patients. With a strong emphasis on technological advancements and continuous research and development, the company strives to stay at the forefront of the diagnostics field. Dian Diagnostics Group Co Ltd's business model revolves around delivering high-quality healthcare services and contributing to the well-being of individuals and communities.

De Dian Diagnostics Group Co K/W is 12,96.

De Dian Diagnostics Group Co KUV is 0,54.

De AlleAktien Kwaliteitsscore voor Dian Diagnostics Group Co is 6/10.

De verwachte Dian Diagnostics Group Co omzet is 14,77 mld. CNY.

De verwachte Dian Diagnostics Group Co winst is 611,58 mln. CNY.

The Dian Diagnostics Group Co. Ltd is a leading Chinese company in the field of medical diagnostics and analysis. It was founded in 2002 and is headquartered in Hangzhou, China. Dian Diagnostics is listed on the Shenzhen Stock Exchange (Code: 300244.SZ) and has been on a rapid growth path for years. The business model of Dian Diagnostics includes various divisions, including laboratory diagnostics, clinical pathology, molecular diagnostics, biological banks, and medical research. The company offers a variety of products and services, including medical tests, diagnostic instruments, research and development services, as well as a wide range of reagents and consumables. Laboratory diagnostics is one of the main business areas of Dian Diagnostics. The company offers a wide range of tests that enable fast and accurate diagnosis. The tests include allergy tests, infection detection, tumor marker tests, and tests for chronic diseases such as diabetes and hypertension. Another important division of the company is clinical pathology, which specializes in the diagnosis of diseases and disorders of the physical condition. Dian Diagnostics offers differentiated diagnostic options to ensure fast and accurate diagnosis of metabolic diseases, rheumatic diseases, cancer, diabetes, and neurological disorders. They also offer services for analyzing disease allergies to identify allergens and thus alleviate the patient's symptoms. Molecular diagnostics is another business area of the company that specializes in the analysis of DNA and RNA samples, enabling targeted diagnosis of genetic diseases. Dian Diagnostics offers a wide range of molecular diagnostic tests, including tests for infectious diseases, cancer, genetic disorders, and reproductive health. Biological banks are another important area of Dian Diagnostics. The company offers secure and reliable storage of biological samples such as blood, cells, tissues, and genetic materials. These are used for medical research and the development of innovative diagnostic and therapy methods. In addition to the mentioned business areas, the company also offers imaging services, such as ultrasound examinations, X-rays, and MRI scans. Overall, the business model of Dian Diagnostics is diverse and covers many important areas of medical diagnostics and analysis. The company benefits from the high demand for medical tests, diagnostic instruments, and research and development services, and is well positioned to capitalize on the growing demand in the industry.

Dian Diagnostics Group Co keert een dividend van 0,14 CNY uit, verdeeld over betalingen per jaar.

De dividend kan momenteel niet worden berekend voor Dian Diagnostics Group Co of het bedrijf keert geen dividend uit.

De ISIN van Dian Diagnostics Group Co is CNE1000015N1.

De ticker van Dian Diagnostics Group Co is 300244.SZ.

Binnen de laatste 12 maanden betaalde Dian Diagnostics Group Co een dividend van 0,20 CNY . Dit komt overeen met een dividendrendement van ongeveer 1,58 %. Voor de komende 12 maanden zal Dian Diagnostics Group Co naar verwachting een dividend van 0,24 CNY betalen.

De dividendrendement van Dian Diagnostics Group Co is momenteel 1,58 %.

Dian Diagnostics Group Co betaalt elk kwartaal een dividend uit. Dit wordt uitgekeerd in de maanden juli, juli, juni, juli.

Dian Diagnostics Group Co betaalde de afgelopen 15 jaar elk jaar dividend.

Voor de komende 12 maanden wordt een dividend van 0,24 CNY verwacht. Dit komt overeen met een dividendrendement van 1,87 %.

Dian Diagnostics Group Co wordt toegewezen aan de sector 'Gezondheid'.

Om het laatste dividend van Dian Diagnostics Group Co van 13-6-2024 ter hoogte van 0,06 CNY te ontvangen, moest je het aandeel voor de ex-datum op 13-6-2024 in je portefeuille hebben.

De laatste dividenduitkering vond plaats op 13-6-2024.

In het jaar 2023 heeft Dian Diagnostics Group Co 0,135 CNY aan dividenden uitgekeerd.

De dividenden van Dian Diagnostics Group Co worden in CNY uitgekeerd.